(Updated - September 4, 2025 5:43 AM EDT)

Guggenheim analyst Brad Canino initiates coverage on Janux Therapeutics (NASDAQ: JANX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE